Matches in Nanopublications for { ?s ?p "[Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- NP27759.RAsU1HxPSNEJ7yCZTURkpRd9TxFeLfrcm-P2879wrxPlE130_assertion description "[Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27759.RAsU1HxPSNEJ7yCZTURkpRd9TxFeLfrcm-P2879wrxPlE130_provenance.
- NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_assertion description "[Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP27729.RAQBLOfSW-Wu3nLSe7U-HV2J7heX5M2t7IxvQNRds1Pxg130_provenance.
- assertion description "[Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_assertion description "[Antifibrotic activity of rofecoxib in vivo is associated with reduced portal hypertension in rats with carbon tetrachloride-induced liver injury.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP20009.RAQVXhHLIaPYll6MmyicMkU_2xJ3jaOI9ERJo6Bd3XFWg130_provenance.